Hydrogen sulfide and the metabolic syndrome

References

• Wang R. Hydrogen sulfide: the third gasotransmitter in biology and medicine. Antioxid. Redox Signal.12(9), 1061–1064 (2010).
   PubMed Web of Science ®Google Scholar
• Gadalla MM, Snyder SH. Hydrogen sulfide as a gasotransmitter. J. Neurochem.113(1), 14–26 (2010).
   PubMed Web of Science ®Google Scholar
• Mustafa AK, Gadalla MM, Snyder SH. Signaling by gasotransmitters. Sci. Signal.2(68), re2 (2009).
   PubMed Web of Science ®Google Scholar
• Yang G, Wu L, Jiang B et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine γ-lyase. Science322(5901), 587–590 (2008).
   PubMed Web of Science ®Google Scholar
• Aschner P. Metabolic syndrome as a risk factor for diabetes. Expert Rev. Cardiovasc. Ther.8(3), 407–412 (2010).
   PubMedGoogle Scholar
• Mottillo S, Filion KB, Genest J et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Cardiol.56(14), 1113–1132 (2010).
   PubMed Web of Science ®Google Scholar
• Weiss R. Metabolic syndrome in childhood – causes and effects. Endocr. Dev.19, 62–72 (2010).
   PubMedGoogle Scholar
• Alberti KG, Zimmet P, Shaw J. The metabolic syndrome – a new worldwide definition. Lancet366(9491), 1059–1062 (2005).
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA287(3), 356–359 (2002).
   PubMed Web of Science ®Google Scholar
• Wu L, Yang W, Jia X et al. Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats. Lab. Invest.89(1), 59–67 (2009).
   PubMedGoogle Scholar
• Yusuf M, Kwong Huat BT, Hsu A, Whiteman M, Bhatia M, Moore PK. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem. Biophys. Res. Commun.333(4), 1146–1152 (2005).
   PubMed Web of Science ®Google Scholar
• Hargrove JL, Trotter JF, Ashline HC, Krishnamurti PV. Experimental diabetes increases the formation of sulfane by transsulfuration and inactivation of tyrosine aminotransferase in cytosols from rat liver. Metabolism38(7), 666–672 (1989).
   PubMedGoogle Scholar
• Nieman KM, Rowling MJ, Garrow TA, Schalinske KL. Modulation of methyl group metabolism by streptozotocin-induced diabetes and all-trans-retinoic acid. J. Biol. Chem.279(44), 45708–45712 (2004).
   PubMedGoogle Scholar
• Jacobs RL, House JD, Brosnan ME, Brosnan JT. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes47(12), 1967–1970 (1998).
   PubMed Web of Science ®Google Scholar
• Gursu MF, Baydas G, Cikim G, Canatan H. Insulin increases homocysteine levels in a dose-dependent manner in diabetic rats. Arch. Med. Res.33(3), 305–307 (2002).
   PubMed Web of Science ®Google Scholar
• Schalinske KL. Interrelationship between diabetes and homocysteine metabolism: hormonal regulation of cystathionine β-synthase. Nutr. Rev.61(4), 136–138 (2003).
   PubMed Web of Science ®Google Scholar
• Yang W, Yang G, Jia X, Wu L, Wang R. Activation of KATP channels by H2S in rat insulin-secreting cells and the underlying mechanisms. J. Physiol.569(Pt 2), 519–531 (2005).
   PubMed Web of Science ®Google Scholar
• Ali MY, Whiteman M, Low CM, Moore PK. Hydrogen sulphide reduces insulin secretion from HIT-T15 cells by a KATP channel-dependent pathway. J. Endocrinol.195(1), 105–112 (2007).
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Kimura Y, Kimura H, Niki I. L-cysteine inhibits insulin release from the pancreatic β-cell: possible involvement of metabolic production of hydrogen sulfide, a novel gasotransmitter. Diabetes55(5), 1391–1397 (2006).
   PubMed Web of Science ®Google Scholar
• Yang G, Yang W, Wu L, Wang R. H2S, endoplasmic reticulum stress, and apoptosis of insulin-secreting β cells. J. Biol. Chem.282(22), 16567–16576 (2007).
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Kimura T, Taniguchi S et al. Glucose-induced production of hydrogen sulfide may protect the pancreatic β-cells from apoptotic cell death by high glucose. FEBS Lett.583(2), 377–382 (2009).
   PubMedGoogle Scholar
• Cao Y, Adhikari S, Ang AD, Moore PK, Bhatia M. Mechanism of induction of pancreatic acinar cell apoptosis by hydrogen sulfide. Am. J. Physiol. Cell. Physiol.291(3), C503–C510 (2006).
   PubMed Web of Science ®Google Scholar
• Robertson RP, Harmon J, Tran PO, Poitout V. β-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in Type 2 diabetes. Diabetes53(Suppl. 1), S119–S124 (2004).
   PubMed Web of Science ®Google Scholar
• Robertson RP, Harmon JS. Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet β cell. Free Radic. Biol. Med.41(2), 177–184 (2006).
   PubMed Web of Science ®Google Scholar
• Hayden LJ, Goeden H, Roth SH. Exposure to low levels of hydrogen sulfide elevates circulating glucose in maternal rats. J. Toxicol. Environ. Health31(1), 45–52 (1990).
   PubMed Web of Science ®Google Scholar
• Feng X, Chen Y, Zhao J, Tang C, Jiang Z, Geng B. Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator. Biochem. Biophys. Res. Commun.380(1), 153–159 (2009).
   PubMed Web of Science ®Google Scholar
• Dhar A, Desai K, Kazachmov M, Yu P, Wu L. Methylglyoxal production in vascular smooth muscle cells from different metabolic precursors. Metabolism57(9), 1211–1220 (2008).
   PubMed Web of Science ®Google Scholar
• Wang H, Meng QH, Gordon JR, Khandwala H, Wu L. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with Type 2 diabetes mellitus. Clin. Biochem.40(16–17), 1232–1239 (2007).
   PubMed Web of Science ®Google Scholar
• McLellan AC, Thornalley PJ, Benn J, Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. (Lond.)87(1), 21–29 (1994).
   PubMed Web of Science ®Google Scholar
• Desai KM, Wu L. Free radical generation by methylglyoxal in tissues. Drug Metabol. Drug Interact.23(1–2), 151–173 (2008).
   PubMedGoogle Scholar
• Wang X, Desai K, Chang T, Wu L. Vascular methylglyoxal metabolism and the development of hypertension. J. Hypertens.23(8), 1565–1573 (2005).
   PubMed Web of Science ®Google Scholar
• Chang T, Wu L. Methylglyoxal, oxidative stress, and hypertension. Can. J. Physiol. Pharmacol.84(12), 1229–1238 (2006).
   PubMed Web of Science ®Google Scholar
• Bourajjaj M, Stehouwer CD, van Hinsbergh VW, Schalkwijk CG. Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus. Biochem. Soc. Trans.31(Pt 6), 1400–1402 (2003).
   PubMed Web of Science ®Google Scholar
• Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc. Diabetol.4(1), 5 (2005).
   PubMed Web of Science ®Google Scholar
• Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol.17(1), 24–38 (2003).
   PubMed Web of Science ®Google Scholar
• Hansel B, Giral P, Nobecourt E et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J. Clin. Endocrinol. Metab.89(10), 4963–4971 (2004).
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest.114(12), 1752–1761 (2004).
   PubMed Web of Science ®Google Scholar
• Wang X, Jia X, Chang T, Desai K, Wu L. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats. J. Hypertens.26(4), 765–772 (2008).
   PubMedGoogle Scholar
• Chang T, Untereiner A, Liu J, Wu L. Interaction of methylglyoxal and hydrogen sulfide in rat vascular smooth muscle cells. Antioxid. Redox Signal.12(9), 1093–1100 (2010).
   PubMed Web of Science ®Google Scholar
• Coppack SW. Adipose tissue changes in obesity. Biochem. Soc. Trans.33(Pt 5), 1049–1052 (2005).
   PubMedGoogle Scholar
• Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J.29(24), 2959–2971 (2008).
   PubMed Web of Science ®Google Scholar
• Whiteman M, Cheung NS, Zhu YZ et al. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem. Biophys. Res. Commun.326(4), 794–798 (2005).
   PubMed Web of Science ®Google Scholar
• Whiteman M, Armstrong JS, Chu SH et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite ‘scavenger’? J. Neurochem.90(3), 765–768 (2004).
   PubMed Web of Science ®Google Scholar
• Laggner H, Muellner MK, Schreier S et al. Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl. Free Radic. Res.41(7), 741–747 (2007).
   PubMed Web of Science ®Google Scholar
• Muellner MK, Schreier SM, Laggner H et al. Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL. Biochem. J.420(2), 277–281 (2009).
   PubMed Web of Science ®Google Scholar
• Whiteman M, Gooding KM, Whatmore JL et al. Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia53(8), 1722–1726 (2010).
   PubMed Web of Science ®Google Scholar
• Jain SK, Bull R, Rains JL et al. Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid. Redox Signal.12(11), 1333–1337 (2010).
   PubMed Web of Science ®Google Scholar
• Zhi L, Ang AD, Zhang H, Moore PK, Bhatia M. Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK–NF-κB pathway. J. Leukoc. Biol.81(5), 1322–1332 (2007).
   PubMed Web of Science ®Google Scholar
• Wang R. Two’s company, three’s a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J.16(13), 1792–1798 (2002).
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J.20(21), 6008–6016 (2001).
   PubMed Web of Science ®Google Scholar
• Cheng Y, Ndisang JF, Tang G, Cao K, Wang R. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am. J. Physiol. Heart Circ. Physiol.287(5), H2316–H2323 (2004).
   PubMed Web of Science ®Google Scholar
• Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am. J. Physiol.250(6 Pt 2), H1145–H1149 (1986).
   PubMed Web of Science ®Google Scholar
• Shesely EG, Maeda N, Kim HS et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA93(23), 13176–13181 (1996).
   PubMed Web of Science ®Google Scholar
• Huang PL, Huang Z, Mashimo H et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature377(6546), 239–242 (1995).
   PubMed Web of Science ®Google Scholar
• Wang R. Hydrogen sulfide: a new EDRF. Kidney Int.76(7), 700–704 (2009).
   PubMed Web of Science ®Google Scholar
• Zhong G, Chen F, Cheng Y, Tang C, Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J. Hypertens.21(10), 1879–1885 (2003).
   PubMed Web of Science ®Google Scholar
• Okamoto K, Yamori Y, Ooshima A, Park C, Haebara H, Matsumoto M. Establishment of the inbred strain of the spontaneously hypertensive rat and genetic factors involved in hypertension. In: Spontaneous Hypertension: its Pathogenesis and Complications. Okamoto K (Ed.) Igaku Shoin, Tokyo, Japan, 1–8 (1972).
   Google Scholar
• Ganten D, Lindpaintner K, Ganten U et al. Transgenic rats: new animal models in hypertension research. Invited lecture. Hypertension17(6 Pt 2), 843–855 (1991).
   PubMed Web of Science ®Google Scholar
• Du J, Yan H, Tang C. Endogenous H2S is involved in the development of spontaneous hypertension. Beijing Da Xue Xue Bao35(1), 102 (2003).
   PubMedGoogle Scholar
• Yan H, Du JB, Tang CS. Changes of endogenous hydrogen sulfide (H2S) in hypertensive rats. Zhonghua Er Ke Za Zhi42(3), 172–175 (2004).
   PubMedGoogle Scholar
• Zhao X, Zhang LK, Zhang CY et al. Regulatory effect of hydrogen sulfide on vascular collagen content in spontaneously hypertensive rats. Hypertens. Res.31(8), 1619–1630 (2008).
   PubMed Web of Science ®Google Scholar
• Lu M, Liu YH, Goh HS et al. Hydrogen sulfide inhibits plasma renin activity. J. Am. Soc. Nephrol.21(6), 993–1002 (2010).
   PubMed Web of Science ®Google Scholar
• Fang L, Zhao J, Chen Y et al. Hydrogen sulfide derived from periadventitial adipose tissue is a vasodilator. J. Hypertens.27(11), 2174–2185 (2009).
   PubMed Web of Science ®Google Scholar
• Takaoka M, Nagata D, Kihara S et al. Periadventitial adipose tissue plays a critical role in vascular remodeling. Circ. Res.105(9), 906–911 (2009).
   PubMed Web of Science ®Google Scholar
• Vela D, Buja LM, Madjid M et al. The role of periadventitial fat in atherosclerosis. Arch. Pathol. Lab. Med.131(3), 481–487 (2007).
   PubMed Web of Science ®Google Scholar
• Wang H, Jiang X, Yang F et al. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine β-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood101(10), 3901–3907 (2003).
   PubMed Web of Science ®Google Scholar
• Dayal S, Bottiglieri T, Arning E et al. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine β-synthase-deficient mice. Circ. Res.88(11), 1203–1209 (2001).
   PubMed Web of Science ®Google Scholar
• Xiaohui L, Junbao D, Lin S et al. Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Circ. J.69(11), 1418–1424 (2005).
   PubMed Web of Science ®Google Scholar
• Li X, Du J, Jin H, Geng B, Tang C. Sodium hydrosulfide alleviates pulmonary artery collagen remodeling in rats with high pulmonary blood flow. Heart Vessels23(6), 409–419 (2008).
   PubMedGoogle Scholar
• Li W, Jin HF, Liu D et al. Hydrogen sulfide induces apoptosis of pulmonary artery smooth muscle cell in rats with pulmonary hypertension induced by high pulmonary blood flow. Chin. Med. J. (Engl.)122(24), 3032–3038 (2009).
   PubMed Web of Science ®Google Scholar
• Wei HL, Zhang CY, Jin HF, Tang CS, Du JB. Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats. Acta Pharmacol. Sin.29(6), 670–679 (2008).
   PubMed Web of Science ®Google Scholar
• Huang XL, Zhou XH, Wei P, Zhang XJ, Meng XY, Xian XH. Role of endogenous hydrogen sulfide in pulmonary hypertension induced by lipopolysaccharide. Sheng Li Xue Bao60(2), 211–215 (2008).
   PubMedGoogle Scholar
• Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes37(12), 1595–1607 (1988).
   PubMed Web of Science ®Google Scholar
• Janka HU. Increased cardiovascular morbidity and mortality in diabetes mellitus: identification of the high risk patient. Diabetes Res. Clin. Pract.30(Suppl.), 85–88 (1996).
   PubMedGoogle Scholar
• Milicevic Z, Raz I, Beattie SD et al. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care31(Suppl. 2), S155–S160 (2008).
   PubMedGoogle Scholar
• Sparatore A, Perrino E, Tazzari V et al. Pharmacological profile of a novel H2S-releasing aspirin. Free Radic. Biol. Med.46(5), 586–592 (2009).
   PubMed Web of Science ®Google Scholar
• Li L, Rossoni G, Sparatore A, Lee LC, Del Soldato P, Moore PK. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic. Biol. Med.42(5), 706–719 (2007).
   PubMed Web of Science ®Google Scholar
• Baskar R, Sparatore A, Del Soldato P, Moore PK. Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur. J. Pharmacol.594(1–3), 1–8 (2008).
   PubMed Web of Science ®Google Scholar
• Distrutti E, Sediari L, Mencarelli A et al. 5-amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. J. Pharmacol. Exp. Ther.319(1), 447–458 (2006).
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Orlandi S, Mencarelli A et al. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br. J. Pharmacol.150(8), 996–1002 (2007).
   PubMed Web of Science ®Google Scholar
• Wallace JL, Caliendo G, Santagada V, Cirino G. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Br. J. Pharmacol.159(6), 1236–1246 (2010).
   PubMed Web of Science ®Google Scholar
• Muzaffar S, Jeremy JY, Sparatore A, Del Soldato P, Angelini GD, Shukla N. H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. Br. J. Pharmacol.155(7), 984–994 (2008).
   PubMedGoogle Scholar
• Shukla N, Rossoni G, Hotston M et al. Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int.103(11), 1522–1529 (2009).
   PubMed Web of Science ®Google Scholar
• Bannenberg GL, Vieira HL. Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulfide. Expert Opin. Ther. Pat.19(5), 663–682 (2009).
   PubMed Web of Science ®Google Scholar
• Wagner F, Asfar P, Calzia E, Radermacher P, Szabo C. Bench-to-bedside review: Hydrogen sulphide – the third gaseous transmitter: applications for critical care. Crit. Care13(3), 213 (2009).
   PubMedGoogle Scholar
• Wallace JL. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol. Sci.28(10), 501–505 (2007).
   PubMed Web of Science ®Google Scholar
• Caliendo G, Cirino G, Santagada V, Wallace JL. Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals. J. Med. Chem.53(17), 6275–6286 (2010).
   PubMed Web of Science ®Google Scholar
• Li L, Whiteman M, Guan YY et al. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation117(18), 2351–2360 (2008).
   PubMed Web of Science ®Google Scholar